Express Press Release Distribution

Accounting
Advertising
Aerospace
Agriculture
Apparel & Fashion
Automotive
Biotech
Chemicals
Computers
Construction
Consumer Services
Defense
Education
Electronics
Energy
Entertainment
Environment
Financial
Food & Beverage
Government
Healthcare
Human Resources
Industrial
International Trade
Internet & Online
Law
Management
Marketing
Media
Non Profit
Pharmaceuticals
Real Estate
Retail
Semiconductors
Small Business
Software
Sports
Telecommunications
Transportation / Logistics
Travel

EPR Archived News

Archived News 2012
~ April
~ March
~ February
~ January

Archived News 2011
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2010
Archived News 2009
Archived News 2008
Archived News 2007
Archived News 2006
Archived News 2005
Archived News 2004

 

Stem Cells From Patient`s Own Bodies Used To Treat Heart Patients at Bangkok Hospital Medical Center

Released on: September 15, 2008, 11:19 pm

Press Release Author: Bangkok Hospital

Industry: Healthcare

Press Release Summary: Bangkok Hospital Medical Centre, in conjunction with the
University of Pittsburgh and Theravitae Ltd, is pioneering a technology that uses a
patient's own stem cells to treat damaged heart muscle and heart failure

Press Release Body: A collaboration between Bangkok Hospital Medical Center,
Theravitae Ltd and the University of Pittsburgh has created a new stem cell therapy
treatment option at Bangkok's world-class hospital and medical facility.

Patients with heart damage or heart failure can now be treated at Bangkok Heart
Hospital (a division of Bangkok Hospital Medical Centre) with stem cells from their
own peripheral blood tissue.
Stem cell therapy involves the use of partially differentiated or undifferentiated
cells to treat damaged tissue in several areas of the body.
Their damaged heart muscle can be repaired without the need for tissue transplants
or mechanical insertions.
The stem cells used are known as angiogenic precursor cells. These cells are
designated as unipotent, that is, they have the potential only to become one type of
mature cell.
However, their undeveloped status means that the body can utilize and reproduce them
in a way it cannot with mature cells.

Cell selection and expansion using this method takes about a week - thousands of
times less what it might take to find a suitable donor for heart tissue.
Magnetic resonance imaging, a thoracoscopic camera and keyhole surgery are used to
administer the stem cell product directly to the damaged area of the heart.

The surgery involves a small incision being made in the left side of the chest, and
a thoracoscopic camera being inserted into the thoracic cavity.
The cells are injected directly into the cardiac muscle at the point of damage,
which is located using an MRI.

The technology also has the potential to be able to grow new heart tissue from a
person's own stem cells, and Bangkok Hospital is leading the world in research in
this area.

The new treatment option at Bangkok Heart Hospital means that medical tourists have
a less invasive, more natural and scientifically advanced method of treatment for
coronary artery disease and heart failure at a world-leading facility.
Bangkok Hospital is accredited by TEMOS (Telemedicine for the Mobile Society), an
organization which assures international travelers of the quality and safety
standards of hospitals worldwide. It also involves a patient's home doctor in the
treatment and recovery process.

For more information, please see
http://www.bangkokhospital.com/App/NewsEventsDetail.aspx?newsid=73 and
www.bangkokhospital.com





Web Site: http://www.bangkokhospital.com

Contact Details: Chris Sharasuvana
e-Marketing Manager
2 Soi Soonvijai 7, New Petchburi Road Bangkapi , Huay Khwang Bangkok
(66) 23 1031 012
chris@bgh.co.th

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •